other material
confidence high
sentiment positive
materiality 0.50
Silo Pharma extends stock repurchase program of up to $1M through March 31, 2024
Silo Pharma, Inc.
- Board approved extension of stock repurchase program authorizing up to $1M in common stock purchases until March 31, 2024.
- As of Dec 31, 2023, company repurchased 264,196 shares for total cost of $487,016 under the program.
- Extension approved on January 9, 2024; original program was previously announced but not detailed.